Funda ukuthi i-Arthri-D3 ihluleka yini ukuphatha i-arthritis noma i-Arthri-D3

Ukuqhathanisa Okuvela E-Infomercial Hype

I-Arthri-D3 iyi-supplementary diet that has been promoted on infomercials TV njengendlela yokukhulula ubuhlungu be-arthritis. Kokubili isimo sewebhu se-infomercial kanye ne-Arthri-D3 ukuthi "ifomula yokuguquguquka ehlanganisa amamaki aphezulu kakhulu e-glucosamine eneziqhumane ezibalulekile zezitshalo."

Izithako ezisebenzayo

Isithako esiyinhloko ku-Arthri-D3 yi- N-acetyl-glucosamine (NAG) , ifomu le-glucosamine elikhiqizwa ngokwemvelo emzimbeni.

Izithako zokudla ezifana ne-Arthri-D3, ifomu elisetshenzisiwe lisuselwa kuma-shells e-crustacean. Ngaphezu kwe-NAG, uhlu lwezithako ezisebenzayo luhlanganisa:

Izinkomba zokusetshenziswa

Azikho izinkomba ezithile ze-Arthri-D3 ngaphandle kokugqugquzela impilo ehlanganisiwe jikelele. Igama elithi "Arthi" lenzelwe ukusikisela ukuthi linemiphumela enesifo samathambo, nakuba kungekho okushiwo ngokuqondile kwe-arthritis noma yisiphi esinye isimo esihlangene (njenge- bursitis noma i- tendinitis ) ekukhangiseni kwenkampani.

I-Arthi-D3 ayikwazi ukusetshenziswa kubantu abane- shellfish yokungezwani komzimba .

Izincomo zesilinganiso

Ibhodlela ngalinye le-Arthri-D3 liqukethe izinyanga ezingu-120 zokuhlinzeka ngamaphilisi angu-120.

Umkhiqizi uncoma ukuthatha ama-capsules amabili ekuseni nama-capsules amabili ntambama noma kusihlwa, okungcono ngokudla. Ngenxa yokuthi i-Vitamin D iyinhlanganisela ye-fat, ingcono kakhulu ekuxhumeni ngokudla.

Umkhiqizi ukhuthaza ukuthi uthathe okungenani izinyanga ezintathu ukuba "uzizwe uhla lwezinzuzo ezigcwele," nakuba kungakaze kuboniswe ukuthi yiziphi lezo zinzuzo.

Izindleko zomkhiqizo

Izindleko zenyanga-ukuhlinzeka kwe-Arthri-D3 yi-$ 104.99 ngemali yokuthumela nokuphatha ye $ 10.49.

Ngokuqhathanisa, izindleko zamaphilisi angu-120 we-vitamin D3 ka-2000 IU cishe angama-$ 8.00. Ngokufanayo, inani le-120-milligram engu-700-milligram ye-NAG isamba ngo-$ 13.00.

Ucwaningo lwezokwelapha

Iwebhusayithi ye-Arthri-D3 ayibhalisi noma yibuphi ubufakazi ekusekeleni izimangalo zayo ngaphandle kokufaka izibuyekezo ezimbalwa ezivela kumakhasimende (amagama okuqala kuphela).

Njengengxenye yokudla, i-Athri-D3 ayidingekile yi-US Food and Drug Administration ukuba ibe nesilinganiso esifanayo sokuhlolwa okunamandla okubonwayo ngezidakamizwa zemithi. Ngenkathi abakhiqizi be-supplemental bezondlo bengavunyelwe ukwenza izimangalo zamanga ngemikhiqizo yabo, imboni yonkana ilawulwa kahle futhi ishiywe yilapho iphoyisa ngokwayo.

Lokhu akusikisela ukuthi i-glucosamine ayisekelwa ngokuphelele ezincekwini zayo kubantu abane-arthritis. Inkinga yukuthi iningi lezifundo, njengalezo ezenziwa eNyuvesi yaseJuntendo eTokyo ngo-2016 no-2017, zincane kakhulu futhi zifitjhani njengokukhawulela nanyana iziphi iziphetho ezingakghona ukuzidweba.

Okunye uphenyo, njengokubuyekezwa kwezifundo ezenziwe yi-University of Liège ngo-2012, zivinjelwe ukusebenzisana nabakhiqizi bezakhi.

Iziphetho

Ngenkathi abacwaningi abaningi bevuma ukuthi i-glucosamine ingase inikeze inzuzo kubantu abanobuhlungu be-arthritis, bazophinde bathi akukho ndlela yokwazi ukuthi yini, uma ikhona, ingathinta isengezo kuzoba nesifo sokuqhubeka nokuthi kungani izinzuzo ezifunwa zifinyelelwa kwezinye izifundo hhayi kwabanye.

Le mbono yabelwe yi-American Academy of Orthopedic Surgeons eyathi: "Akukho bufakazi bokuthi [glucosamine] empeleni iyophuza inqubo eguqukayo noma ibuyiselwe i-cartilage ezinxenyeni ze-arthritic."

> Imithombo:

> I-American Academy Yabahlinzeki Bama-Orthopedic (AAOS). (2009) "iGlucosamine neCondroitin Sulfate." I-AAOS Research Committee sheet, i-Osteoarthritis ne-Arthritis Foundation. Rosemont, Illinois: i-AAOS.

> Henrotin, Y .; Mobasheri, A .; futhi uMarty, M. "Ingabe kukhona ubufakazi besayense bokusetshenziswa kwe-glucosamine ekulawulweni kwe-osteoarthritis yabantu?" I-Arthritis Res Ther. 2012; 14 (1): 201. I-DOI: 10.1186 / ar3657.

> Kubomura, D .; Ueno, T .; Yamada, M. et al. "Umphumela we-N-acetylglucosamine wokulawula ukuqina kwamathambo nokuphepha ezintweni ezinempilo ngaphandle kwezimpawu ze-arthritis: Umbiko wecala." Exp Ther Med. 2017; 13 (4): 1614-21. I-DOI: 10.3892 / etm.2017.4140.

> Tomonaga, A .; I-Watanabe, K .; Fukagawa, M. et al. "Ukuhlolwa komphumela we-N-acetyl-glucosamine ukulawulwa kwezidakamizwa ze-cartilage metabolism kubantu abanempilo ngaphandle kwezibonakaliso zesifo samathambo: isifundo somtholampilo esilawulwa yi-placebo esingahleliwe." Exp Ther Med. 2016; 12 (3): 1481-89. I-DOI: 10.3892 / etm.2016.3480.